2014年度 業績

循環器グループ

  1. Okamoto N, Noma T, Ishihara Y, Miyauchi Y, Takabatake W, Oomizu S, Yamaoka G, Ishizawa M, Namba T, Murakami K, Iwado Y, Ohmori K, Kohno M. Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction. Int Heart J. 2014;55(3):271-7.
  2. Hasan AU, Ohmori K, Hashimoto T, Kamitori K, Yamaguchi F, Ishihara Y, Ishihara N, Noma T, Tokuda M, Kohno M. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity. Hypertens Res. 2014;37(7):621-8

腎臓グループ

  1. Sofue T, Inui M, Hara T, Moriwaki K, Kushida Y, Nishiyama A, Kakehi Y, Kohno M. Short-term prognosis of living-donor kidney transplantation from hypertensive donors with high-normal albuminuria. Transplantation 2014; 97(1):104-110
  2. Nishioka S, Nakano D, Kitada K, Sofue T, Ohsaki H, Moriwaki K, Hara T, Ohmori K, Kohno M, Nishiyama A. p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia-reperfusion injury in mice. Kidney Int 2014, 85(4), 871-879
  3. Sofue T, Hayashida Y, Hara T, Kawakami K, Ueda N, Kushida Y, Inui M, Dobashi H, Kakehi Y, and Kohno M. Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report. BMC Nephrology 2014; 167: 7
  4. Nishioka S, Sofue T, Inui M, Nishijima Y, Moriwaki K, Hara T, Mashiba T, Kakehi Y, Kohno M. Mineral and Bone Disorder is Temporary in Patients Treated with Early Rapid Corticosteroid Reduction after Kidney Transplantation: A Single-Center Experience. Transplant Proc. 2014;46(2):514-20.
  5. Sofue T, Inui M, Hara T, Nishijima Y, Moriwaki K, Hayashida Y, Ueda N, Nishiyama A, Kakehi Y, Kohno M. The efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients. Drug Des Devel Ther. 2014:8; 245–253